Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New ...

topotecan, irinotecan, or gemcitabine). The trial was stopped early, following a unanimous recommendation by the Independent Data Monitoring Committee, based on the highly significant effect of ...